Trimedyne (TMED) Stock Chart & Stock Price History $25.64 -0.27 (-1.04%) As of 09/15/2025 02:51 PM Eastern Add Compare Share Share Chart Stock AnalysisChartBuy This Stock Trimedyne Stock Price Performance The Trimedyne (TMED) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 503.29%, with a year-to-date return of 503.29%. In the past month, the stock has increased 1.79%, reflecting recent market activity. As of the latest close, Trimedyne traded at $25.64 with a market cap of $10.26 million and volume of 362 shares. Five years ago, the stock traded at $4.25, representing a 503.29% increase over that period. At the time, it had a market cap of $0.00 and a volume of 100 shares. Receive TMED Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-2.44%1 Month Performance+1.79%3 Month Performance+3.18%Year-To-Date Performance+503.29%1 Year Performance+503.29%5 Year Performance+503.29% TMED Stock Chart for Tuesday, September, 16, 2025 TMED Chart by TradingView Trimedyne Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/15/2025$25.91$25.64-1.04%$25.76$25.64362 shs$10.26 million09/12/2025$26.28$25.91-1.41%$26.18$25.911,060 shs$10.36 million09/11/2025$25.78$26.28+1.94%$26.29$26.111,257 shs$10.51 million09/10/2025$26.05$25.78-1.04%$25.90$25.702,964 shs$10.31 million09/09/2025$25.89$26.05+0.62%$26.05$25.912,640 shs$10.42 million09/08/2025$25.83$25.89+0.23%$25.89$25.80486 shs$10.36 million09/05/2025$25.51$25.83+1.25%$25.92$25.654,510 shs$10.33 million09/04/2025$25.40$25.51+0.43%$25.51$25.371,240 shs$10.20 million09/03/2025$25.43$25.40-0.12%$25.40$25.407 shs$10.16 million09/02/2025$25.24$25.43+0.75%$25.43$25.4354 shs$10.17 million Get the Latest News and Ratings for TMED and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter. 09/01/2025$25.24$25.24$25.24$25.245 shs$10.10 million08/29/2025$25.17$25.24+0.28%$25.24$25.245 shs$10.10 million08/28/2025$25.28$25.17-0.44%$25.17$25.171 shs$10.07 million08/27/2025$25.28$25.28$25.28$25.2859 shs$10.11 million08/26/2025$24.99$25.28+1.16%$25.28$25.2873 shs$10.11 million08/25/2025$25.43$24.99-1.73%$25.30$24.99467 shs$10.00 million08/22/2025$25.15$25.43+1.11%$25.56$25.432,091 shs$10.17 million08/21/2025$25.16$25.15-0.04%$25.28$25.151,104 shs$10.06 million08/20/2025$25.13$25.16+0.12%$25.16$25.054,227 shs$10.06 million08/19/2025$25.15$25.13-0.08%$25.17$25.12482 shs$10.05 million08/18/2025$25.19$25.15-0.16%$25.36$25.151,523 shs$10.06 million08/15/2025$24.70$25.19+1.98%$25.22$25.051,962 shs$10.08 million Related Companies NeurAxis Stock Chart Heyu Biological Technology Stock Chart ViewRay Stock Chart Magna-Lab Stock Chart Viveve Medical Stock Chart Aksys Stock Chart Electromed Stock Chart QT Imaging Stock Chart OneMedNet Stock Chart ParkerVision Stock Chart Receive TMED Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:TMED) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trimedyne, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trimedyne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
